Patents by Inventor Patrick Maurel

Patrick Maurel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TREATMENT AND PREVENTION OF INJURY DUE TO RADIATION EXPOSURE
    Publication number: 20240000832
    Abstract: The disclosure relates to the treatment and/or prevention of radiation damage by administering a reverse micelle system.
    Type: Application
    Filed: September 14, 2023
    Publication date: January 4, 2024
    Inventors: Elsa COMPTE, Patrick MAUREL, Sophie GRIVES-JERPHAGNON, Cyril LAVAUD, Lorraine BENIGNO-ANTON, Jean-Claude MAUREL
  • Treatment and prevention of injury due to radiation exposure
    Patent number: 11793831
    Abstract: The disclosure relates to the treatment and/or prevention of radiation damage by administering a reverse micelle system.
    Type: Grant
    Filed: July 5, 2019
    Date of Patent: October 24, 2023
    Assignee: MEDESIS PHARMA
    Inventors: Elsa Compte, Patrick Maurel, Sophie Grives-Jerphagnon, Cyril Lavaud, Lorraine Benigno-Anton, Jean-Claude Maurel
  • TREATMENT AND PREVENTION OF INJURY DUE TO RADIATION EXPOSURE
    Publication number: 20210315931
    Abstract: The disclosure relates to the treatment and/or prevention of radiation damage by administering a reverse micelle system.
    Type: Application
    Filed: July 5, 2019
    Publication date: October 14, 2021
    Inventors: Elsa COMPTE, Patrick MAUREL, Sophie GRIVES-JERPHAGNON, Cyril LAVAUD, Lorraine BENIGNO-ANTON, Jean-Claude MAUREL
  • Nucleic acid construct comprising nucleic acid derived from genome of hepatitis C virus of genotype 3a
    Patent number: 9453056
    Abstract: A nucleic acid includes, in the following order, a 5? untranslated region comprising a particular nucleotide sequence of the genome of hepatitis C virus genotype 3a; a nucleotide sequence encoding a particular amino acid sequence of an NS3 protein, a nucleotide sequence encoding a particular amino acid sequence of an NS4A protein, a nucleotide sequence encoding a particular amino acid sequence of an NS4B protein, a nucleotide sequence encoding a particular amino acid sequence of an NS5A protein, a nucleotide sequence encoding a particular amino acid sequence of an NS5B protein of the hepatitis C virus genotype 3a; and a 3? untranslated region comprising a particular nucleotide sequence of a genome of hepatitis C virus genotype 3a.
    Type: Grant
    Filed: August 31, 2012
    Date of Patent: September 27, 2016
    Assignees: Japan as Represented by Director-General of National Institute of Infectious Diseases, Inserm Institut National de la Sante et de la Recherche Medicale, Toray Industries, Inc.
    Inventors: Takaji Wakita, Mohsan Saeed, Patrick Maurel, Claire Gondeau, Hiroshi Yokokawa
  • NUCLEIC ACID CONSTRUCT COMPRISING NUCLEIC ACID DERIVED FROM GENOME OF HEPATITIS C VIRUS OF GENOTYPE 3a
    Publication number: 20140286995
    Abstract: A nucleic acid includes, in the following order, a 5? untranslated region comprising a particular nucleotide sequence of the genome of hepatitis C virus genotype 3a; a nucleotide sequence encoding a particular amino acid sequence of an NS3 protein, a nucleotide sequence encoding a particular amino acid sequence of an NS4A protein, a nucleotide sequence encoding a particular amino acid sequence of an NS4B protein, a nucleotide sequence encoding a particular amino acid sequence of an NS5A protein, a nucleotide sequence encoding a particular amino acid sequence of an NS5B protein of the hepatitis C virus genotype 3a; and a 3? untranslated region comprising a particular nucleotide sequence of a genome of hepatitis C virus genotype 3a.
    Type: Application
    Filed: August 31, 2012
    Publication date: September 25, 2014
    Applicants: Japan as Represented by Director-General of National Institute of Infectious Diseases, Toray Industries, Inc., INSERM Institutut National de la Sante et de la Recherche Medicale
    Inventors: Takaji Wakita, Mohsan Saeed, Patrick Maurel, Claire Gondeau, Hiroshi Yokokawa
  • Method of culturing liver cells over long time
    Publication number: 20050130300
    Abstract: A method of culturing hepatocytes for a long term, characterized in that fresh hepatocytes are maintained in a medium at 15 to 30° C. for 1 to 6 days, followed by culturing under physiological conditions. The method of the present invention enables hepatocytes to be cultured for a long term without inviting reduction in enzymatic activity or enzyme-inducing activity. Moreover, since the cells can be maintained at around room temperature for 1 to 6 days, the method is very useful for long-term transportation of hepatocytes after isolation.
    Type: Application
    Filed: April 4, 2002
    Publication date: June 16, 2005
    Inventors: Noriaki Shimada, Patrick Maurel